FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for Tafluprost Ophthalmic submitted by Prasco Laboratories. Tafluprost ophthalmic is used to lower intraocular press…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• TAFLUPROST OPHTHALMIC (TAFLUPROST)

Snippet

SUPPL AP for TAFLUPROST OPHTHALMIC (TAFLUPROST)